Flow cytometric analysis revealed that CVB-D treatment induced an obvious apoptotic phenotype in lung cancer cells in a dose-dependent manner (Figure 1G), which can be further confirmed by the increased cleavage of caspase 3 and PARP under CVB-D treatment (Figure 1H). Here, CASP3 is linked to lung carcinoma.